Evidence map›Paper›PMID 22211101›Full record

ArticleInternational journal of biological sciences2012

Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells.

Julia Wachter, Daniel Neureiter, Beate Alinger, Martin Pichler, Julia Fuereder, Christian Oberdanner, Pietro Di Fazio, Matthias Ocker, Frieder Berr, Tobias Kiesslich

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Miniaturization of the Clonogenic Assay Using Confluence Measurement.International journal of molecular sciences · 2018
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Julia WachterDepartment of Internal Medicine I, Paracelsus Medical University / Salzburger Landeskliniken (SALK), Muellner Hauptstrasse 48, 5020 Salzburg, Austria.
Daniel Neureiter
Beate Alinger
Martin Pichler
Julia Fuereder
Christian Oberdanner
Pietro Di Fazio
Matthias Ocker
Frieder Berr
Tobias Kiesslich
Paracelsus Medical University · ATPhilipps University of Marburg · DESalzburger Landeskliniken · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe role of Wnt signalling in carcinogenesis suggests compounds targeting this pathway as potential anti-cancer drugs. Several studies report activation of Wnt signalling in biliary tract cancer (BTC) thus rendering Wnt inhibitory drugs as potential candidates for targeted therapy of this highly chemoresistant disease.

methodsIn this study we analysed five compounds with suggested inhibitory effects on Wnt signalling (DMAT, FH535, myricetin, quercetin, and TBB) for their cytotoxic efficiency, mode of cell death, time- and cell line-dependent characteristics as well as their effects on Wnt pathway activity in nine different BTC cell lines.

resultsExposure of cancer cells to different concentrations of the compounds results in a clear dose-dependent reduction of viability for all drugs in the order FH535 > DMAT > TBB > myricetin > quercetin. The first three substances show high cytotoxicity in all tested cell lines, cause a direct cytotoxic effect by induction of apoptosis and inhibit pathway-specific signal transduction in a Wnt transcription factor reporter activity assay. Selected target genes such as growth-promoting cyclin D1 and the cell cycle progression inhibitor p27 are down- and up-regulated after treatment, respectively.

conclusionsTaken together, these data demonstrate that the small molecular weight inhibitors DMAT, F535 and TBB have a considerable cytotoxic and possibly Wnt-specific effect on BTC cell lines in vitro. Further in vivo investigation of these drugs as well as of new Wnt inhibitors may provide a promising approach for targeted therapy of this difficult-to-treat tumour.

Indexed as

Antineoplastic AgentsBenzimidazolesbeta CateninBiliary Tract NeoplasmsCadherinsCell Line, TumorCell SurvivalClinical Trials as TopicCyclin D1FlavonoidsGene Expression Regulation, NeoplasticGenes, p53HumansKi-67 AntigenProliferating Cell Nuclear AntigenQuercetin2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole4,5,6,7-tetrabromo-2-azabenzimidazoleAntineoplastic AgentsBenzimidazolesbeta CateninCadherinsCyclin D1FH535FlavonoidsKi-67 Antigenmyricetinp27 antigenProliferating Cell Nuclear AntigenQuercetinRNA, MessengerSulfonamidesTriazolesVimentinApoptosisBiliary Tract CancerCytotoxicitypharmacological inhibitionWnt pathway

Identifiers

PMID22211101
PMCPMC3226029
OpenAlexW2116992727

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.